Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peterse

Showing results (241-250 of 339) with videos related to

Pageof 34
Sort By:
Vaccine|December 1, 2010
IL-15 aggravates atherosclerotic lesion development in LDL receptor deficient miceThomas van Es, Gijs H M van Puijvelde, Ingrid N Michon, et al.
The Journal of Pathology|March 13, 1998
Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situW J De Leeuw, G Berx, C B Vos, et al.
Cancer Research|October 1, 1992
Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancerE Schuuring, E Verhoeven, H van Tinteren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trialsA C Voogd, M Nielsen, J L Peterse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853N Bijker, J L Peterse, L Duchateau, et al.
The Journal of Pathology|September 2, 2003
Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomasEls C Robanus-Maandag, Cathy A J Bosch, Petra M Kristel, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancerE E Deurloo, P J Tanis, K G A Gilhuijs, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 25, 1999
The relationship between findings on pre-treatment mammograms and local recurrence after breast-conserving therapy for invasive breast cancerA C Voogd, F van der Horst, M A Crommelin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 21, 2019
Cost-effectiveness of Active Identification and Subsequent Colonoscopy Surveillance of Lynch Syndrome CasesElisabeth F P Peterse, Steffie K Naber, Corinne Daly, et al.
Journal of Clinical Pathology|February 25, 2006
The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinomaG Cserni, S Bianchi, V Vezzosi, et al.
Pageof 34

Showing results (241-250 of 339) with videos related to

Sort By:
Pageof 34
Vaccine|December 1, 2010
IL-15 aggravates atherosclerotic lesion development in LDL receptor deficient miceThomas van Es, Gijs H M van Puijvelde, Ingrid N Michon, et al.
The Journal of Pathology|March 13, 1998
Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situW J De Leeuw, G Berx, C B Vos, et al.
Cancer Research|October 1, 1992
Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancerE Schuuring, E Verhoeven, H van Tinteren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trialsA C Voogd, M Nielsen, J L Peterse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853N Bijker, J L Peterse, L Duchateau, et al.
The Journal of Pathology|September 2, 2003
Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomasEls C Robanus-Maandag, Cathy A J Bosch, Petra M Kristel, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancerE E Deurloo, P J Tanis, K G A Gilhuijs, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 25, 1999
The relationship between findings on pre-treatment mammograms and local recurrence after breast-conserving therapy for invasive breast cancerA C Voogd, F van der Horst, M A Crommelin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 21, 2019
Cost-effectiveness of Active Identification and Subsequent Colonoscopy Surveillance of Lynch Syndrome CasesElisabeth F P Peterse, Steffie K Naber, Corinne Daly, et al.
Journal of Clinical Pathology|February 25, 2006
The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinomaG Cserni, S Bianchi, V Vezzosi, et al.
Pageof 34